MétaCan
Menu
Back to cohort

Systematic review of prognostic models for cardiomyopathy and heart failure applicable to survivors of adolescent and young adult cancer.

2025· article· en· W4410795431 on OpenAlexafffund
Louise Guolla, J. BRENDAN M. MULLEN, Andrés Felipe Fajardo, Kriti Kakar, Lehana Thabane, Sumit Gupta, Paul C. Nathan

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicChemotherapy-induced cardiotoxicity and mitigation
Canadian institutionsHospital for Sick ChildrenUniversity of TorontoMcMaster UniversityMcGill UniversityImpact
FundersCanadian Institutes of Health Research
KeywordsMedicineHeart failureCardiomyopathyCancerInternal medicineCardiologyOncologyIntensive care medicine

Abstract

fetched live from OpenAlex

12037 Background: Survivors of adolescent and young adult (AYA) cancer who receive cardiotoxic chemotherapy and/or radiation are at risk of developing cancer therapy-related cardiac dysfunction (CTRCD), including asymptomatic reduction in left ventricular ejection fraction and symptomatic heart failure. Early detection and intervention using risk-adapted surveillance strategies can reduce morbidity and mortality. While numerous risk prediction models (RPM) have been developed and/or validated for CTRCD in pediatric or older adult cancer populations, it is unclear whether they can be applied to survivors of AYA cancer. Methods: We undertook a systematic review of cardiovascular RPM (including CTRCD) development/ validation studies in survivors of cancer diagnosed at any age. We searched MEDLINE, EMBASE, and Web of Science with additional hand searching until November 2024. Two reviewers screened abstracts and full texts; we included studies that used real-life patient data to predict asymptomatic or symptomatic CTRCD (per European Society of Cardiology guidelines) ≥1 year from diagnosis and after completing therapy. We excluded abstracts, non-English studies, and RPM which used data not routinely accessible in outpatient clinics. We extracted study data and applied the Prediction model Risk of Bias ASsessment Tool for risk of bias (RoB) and applicability to AYA cancer survivors. When not reported, we estimated AYA (age 15-39) proportions using cancer incidence patterns. We used descriptive statistics to evaluate studies, models, included risk factors, and participants overall and by proportion of AYA. Meta-analysis was not possible given limited overlap in the identified models. Results: We screened 12740 abstracts and 249 full text articles; of these, 100 studies underwent a second full text screen to identify CTRCD models. We identified 22 studies (7 enrolled > 20% AYA) which developed and/or validated 64 models (32.8% machine learning) to predict CTRCD (54.7% symptomatic) in 129077 cancer survivors (10.7% AYA) using clinically available data. Nine (14.1%) models validated existing RPM (e.g. those developed in non-cancer populations); the remainder were newly developed models, with age at diagnosis, diabetes, hypertension, and anthracycline dose the most common predictors ( > 50% of models). Most models (n = 54) were at high RoB, primarily due to concerns with analytical reporting. Only 2 studies/8 models were rated as both low RoB and high applicability to AYA survivors. Conclusions: Several RPM for subclinical and overt CHF are available for pediatric and adult cancer survivors, with varying applicability to AYA cancer survivors. Adherence to recommended statistical reporting methods is poor and RoB high, further limiting utility. Additional development and validation of high-quality RPM for heart failure in AYA cancer survivors is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.020
metaresearch head score (Gemma)0.098
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.020
Threshold uncertainty score0.108

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0200.098
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0120.014
Bibliometrics0.0150.012
Science and technology studies0.0010.001
Scholarly communication0.0030.003
Open science0.0030.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.414
Teacher spread0.368 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicChemotherapy-induced cardiotoxicity and mitigationFrench-language works237,207